Completed NA NCT00493363
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
Sponsor: FHI 360
Conditions
Falciparum Malaria
Interventions
Artesunate Artesunate + Mefloquine
Updated 5 times since 2017 Last updated: May 1, 2018 Started: Jun 30, 2007 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009
A NA clinical study on Falciparum Malaria, this trial is completed. The trial is conducted by FHI 360 and has accumulated 5 data snapshots since 2007. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- FHI 360
- Institut Pasteur
- Li Ka Shing Foundation
- Mahidol University
- NCHADS - Ministry of Health of Cambodia
- University of Oxford
- World Health Organization
Data source: University of Oxford
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Pailin, Cambodia